0.7597
Schlusskurs vom Vortag:
$0.7903
Offen:
$0.73
24-Stunden-Volumen:
361.60K
Relative Volume:
3.05
Marktkapitalisierung:
$1.38M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.59M
KGV:
-0.000553
EPS:
-1373
Netto-Cashflow:
$-9.25M
1W Leistung:
+8.51%
1M Leistung:
+8.53%
6M Leistung:
-51.30%
1J Leistung:
-80.67%
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Firmenname
Bluejay Diagnostics Inc
Sektor
Branche
Telefon
(978) 631-0152
Adresse
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Vergleichen Sie BJDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
BJDX
Bluejay Diagnostics Inc
|
0.7597 | 1.43M | 0 | -8.59M | -9.25M | -1,373.00 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bluejay Diagnostics Inc Aktie (BJDX) Neueste Nachrichten
Bluejay Diagnostics announces 1-for-4 reverse stock split - Investing.com
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split - marketscreener.com
Bluejay Diagnostics cuts share count to ~708K in 1-for-4 reverse split - Stock Titan
Valuation Update: Is Bluejay Diagnostics Inc stock a smart retirement pick2025 Buyback Activity & Stepwise Trade Execution Plans - baoquankhu1.vn
Investment Report: How is Bluejay Diagnostics Inc managing supply chain issuesJuly 2025 Gainers & Community Verified Trade Signals - baoquankhu1.vn
Published on: 2026-01-14 07:07:38 - Bộ Nội Vụ
Buybacks Report: Is Bluejay Diagnostics Inc forming a breakout patternTrade Ideas & Community Shared Stock Ideas - baoquankhu1.vn
How Bluejay Diagnostics Inc. stock trades before earnings2025 Major Catalysts & Proven Capital Preservation Methods - ulpravda.ru
Bluejay Diagnostics Inc. (BJDX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Bluejay Diagnostics Raises $3.7M Through Warrant Deal, Stock Slides After-Hours While Retail Interest Surges - MSN
Why Bluejay Diagnostics Inc. stock remains a top recommendationJuly 2025 Setups & Technical Pattern Alert System - Улправда
How supply chain issues affect Bluejay Diagnostics Inc. stockSell Signal & Entry Point Confirmation Alerts - ulpravda.ru
Is Bluejay Diagnostics Inc. stock attractive for passive investorsQuarterly Profit Review & Daily Chart Pattern Signals - Улправда
Is Bluejay Diagnostics Inc. stock a safe haven assetJuly 2025 Action & AI Optimized Trade Strategies - Улправда
Can Bluejay Diagnostics Inc. stock beat market expectations this quarter - Улправда
Is Bluejay Diagnostics Inc. stock a defensive play in 2025MACD Histogram Signals & Subscribe for Free Weekly Winners - ulpravda.ru
2026 world cup star players tips: Why Bluejay Diagnostics Inc. stock could see breakout soon2026 world cup usa national team group stage goalkeepers transition play knockout prediction insights - ulpravda.ru
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
What analysts say about Bluejay Diagnostics Inc stockPortfolio Diversification Tips & Outstanding Growth Stocks - earlytimes.in
Why Bluejay Diagnostics Inc. stock could see breakout soonRSI Overbought/Oversold & Big Profit Small Budget - bollywoodhelpline.com
Bluejay Diagnostics Completes Commercial-Scale IL-6 Antibody Production - TradingView — Track All Markets
Working capital per share of Bluejay Diagnostics, Inc. – NASDAQ:BJDX - TradingView — Track All Markets
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Sees Significant Increase in Short Interest - Defense World
Bluejay Diagnostics completes antibody production for IL-6 test system By Investing.com - Investing.com Nigeria
Bluejay Diagnostics announces completion of commercial-scale IL-6 antibody production - marketscreener.com
Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production - TradingView — Track All Markets
Bluejay Diagnostics completes antibody production for IL-6 test system - Investing.com
Bluejay Diagnostics, Inc. Completes Commercial-Scale Production of IL-6 Antibodies for Symphony™ System - Quiver Quantitative
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Enough IL-6 test antibodies made to power 9M diagnostic cartridges - Stock Titan
Bluejay Diagnostics Stock Plummets 37% With 11-Day Losing Streak - Trefis
10-Day Sell-Off Sends Bluejay Diagnostics Stock Down 34% - Trefis
Can Bluejay Diagnostics Inc. stock hit record highs againWeekly Market Report & Entry Point Strategy Guides - Улправда
What makes Bluejay Diagnostics Inc. stock attractive to growth fundsWeekly Market Outlook & Free Safe Capital Growth Stock Tips - DonanımHaber
Bluejay Diagnostics Earnings Notes - Trefis
This trade activity should not be overlooked: Bluejay Diagnostics Inc (BJDX) - Setenews
Can Bluejay Diagnostics Inc. stock sustain institutional interestJuly 2025 Reactions & Short-Term High Return Strategies - Newser
Bluejay Diagnostics (BJDX) Stock Analysis Report | Financials & Insights - Benzinga
Bluejay Diagnostics (NASDAQ:BJDX) Shares Down 6.2% – Time to Sell? - Defense World
Finanzdaten der Bluejay Diagnostics Inc-Aktie (BJDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):